These results strongly suggest that the causal relationship between the Aβ accumulation and the neuropathological defects usually associated with AD may be challenged and position the AICD as a good candidate to explain the effects observed in various transgenic models based on mutations in APP and PS1. The gene discussed is APP; the disease is Alzheimer disease.